We therefore assessed the cell growth and survival of MYD88-mutated WM and ABC DLBCL cells, including MYD88/CD79B mutated TMD8 and HBL-1 cells using CellTiter-Glo® Luminescent cell viability assay following SYK knockdown by lentiviral transduction. This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma.